Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
SafeConsumE: Safer food through changed consumer behavior: Effective tools and products, communication strategies, education and a food safety policy reducing health burden from foodborne illnesses (SafeConsumE)

Framework: Horizon 2020 — Societal Challenges
Programme: Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy
Theme: Sustainable and competitive agri-food sector for a safe and healthy diet
Action type: Research and Innovation actions
Countries involved: Spain,Germany,Romania,Switzerland,Norway,Greece,Hungary,Hungary,Romania,Türkiye,Sweden,Belgium,Norway,France,France,France,Denmark,United Kingdom,Denmark,United Kingdom,Portugal,United Kingdom,United Kingdom,Portugal,United Kingdom
Call: The impact of consumer practices in food safety: risks and mitigation strategies (H2020-SFS-2016-2, 2016)
Start date: 2017-05-01
End date: 2022-10-31
Duration (months): 66.0
Total project cost (EUR): 9500000.0
EU funding (EUR): 9500000.0
Participants: 36
Project status: CLOSED

Food safety violations at the consumer stage are common and nearly 40% of food-borne outbreaks are occurring in the domestic setting. The overall goal of SafeConsumE is to provide effective, science-based and sustainable strategies for food authorities, market actors and the research community to help consumers mitigate risk, thus reducing the health burden from food-borne illness in Europe. SafeconsumE will suggest, develop and evaluate: 1) Tools, technologies and products (e.g. sensors, apps, hygiene concepts, kitchen utensils) that stimulate safe practices; 2) Communication strategies that effectively stimulate adoption and market uptake of safer practices and tools/technologies; 3) Education programs increasing skills and knowledge aiding teenagers to handle food safely; 4) Dynamic, sustainable and inclusive policy models that stimulates and support national and EU level initiatives. To achieve high implementation and innovation power, scientists will work together with consumers, authorities and different market actors under a new trans-disciplinary and multi-actor approach based on Theories of Practices combined with Design-driven innovation. Covering the five most important hazards causing food borne disease, consumer behavior across Europe will be described using a risk-based methodology and utilizing the strengths of high-throughput surveys together with in-depth qualitative methodology. New strategies will be developed taking into account their impact on risk reduction, documented consumer barriers for change and sustainability. SafeConsumE will support transformation towards a more healthy population and cost-efficacy by reduced foodborne illness, and a more sustainable community by less food-waste and environmentally friendly solutions.

Keywords: pathogen agents,knowledge transfer,cultural studies,consumers,education
A New Perspective On Star Formation and Spiral Structure in Our Home Galaxy (PERSEUS)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: United Kingdom
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2018-05-01
End date: 2020-04-30
Duration (months): 24.0
Total project cost (EUR): 183454.8
EU funding (EUR): 183454.8
Participants: 1
Project status: CLOSED

Giant molecular clouds (GMCs) are the principal sites of star formation. The derivation of cloud properties are complicated by their large spread in distance along the line of sight. Consequently, to gain insight into the GMCs' physical states one compares parsec-sized clouds of a few hundred solar masses in the solar neighbourhood to the largest, million-solar-mass GMCs in the distant Milky Way. The main goal of my project is to produce the first map of the Perseus Spiral Arm in our outer Galaxy as would be seen by an external observer at fixed spatial resolution. The Perseus Arm extends over one third of the Milky Way's observed span and covers different environmental conditions. HI, 12CO and 13CO data of the Perseus Arm will be convolved to the same spatial resolution and regridded onto maps of constant linear scale. I will extract a fundamental benchmark sample of GMCs using cloud-finding algorithms for comparison with GMCs in the inner Galaxy to study the impact of different kinds of environments. I will reproject the Perseus Arm maps to any desired spatial resolution, to match and compare with observations of nearby galaxies. The phase balance between the atomic and molecular gas, the clump and star formation efficiency will be derived to investigate the relation between spiral arms and star formation. This first common resolution study of the Milky Way's GMCs will be of benefit for the galactic and extragalactic community and allow me to broaden my expertise and skills in the inner Galaxy to a new environment in the outer Galaxy. I will be able to expand my network through collaboration in the field and with colleagues from Exeter. My goal to place the Milky Way in the context of other galaxies with extragalactic collaboration will enable me to become one of the few experts in the field, which will help me to achieve my long-term goal to obtain a permanent academic position.

Keywords: perseus spiral arm,physical properties of molecular clouds,star formation,atomic and molecular gas,milky way,extragalactic studies,common resolution mapping
Low cost, long durability rechargeable Green Battery based on Zn and MnO2 electrodes. (TT-Battery)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Action type: SME instrument
Countries involved: Italy
Call: Stimulating the innovation potential of SMEs for a low carbon and efficient energy system (H2020-SMEINST-1-2016-2017, 2017)
Start date: 2018-02-01
End date: 2018-07-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

TT-Battery project deals with the validation, industrialization and commercialization of an innovative electrochemical storage device, patented by the Proposer TTSB S.r.l. and able to achieve unparalleled targets in terms of cost and durability. The rechargeable battery technology is based on cost-effective materials, such as zinc and manganese, which are non-polluting, safe and abundant in nature. The device comprises a zinc anode, a patented manganese dioxide (MnO2) cathode and an aqueous solution of zinc sulfate (ZnSO4) as electrolyte. Its architecture is simple, does not require maintenance and the battery is non-polluting, non-toxic, non-acid, non-corrosive, non-explosive. The technology developed delivers breakthrough properties: • the battery is able to perform more than 5000 cycles of charging and discharging, with a capacity loss under 10%. • The innovative and patented cathode material (MnO2 decorated with copper hexacyanoferrate), with specific capacity equal or higher than 300 mAh/g, provides the battery with high energy density (> 250 Wh/kg). • The low-cost materials used and the simple architecture leads to a target cost of production (CoP) < 150 €/kWh and a market price = 250 €/kWh, in line with the Pb-acid batteries and pumped hydro systems cost (the benchmark in the stationary storage sector). Thanks to TT-Battery "killer" solution, batteries technology will overcome the pumped hydro systems competition and allow to achieve the stationary energy storage EU targets. The Business opportunity is huge: a Boston Consulting Group report ("Revising Energy Storage" ) quantifies 140 bln$ of global investments in stationary battery power by 2030, while Citigroup is even more optimistic, assuming 400 bln$ in investments and 240 GW/year in installations by 2030.

Keywords: rechargeable battery,stationary energy storage,green battery,battery durability
Ship performance monitoring and simulation to reduce fuel consumption and emissions. (SuPREmE)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Netherlands
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2019)
Start date: 2019-09-01
End date: 2019-12-31
Duration (months): 4.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Today, 90% of all transported goods in the world are transported by sea, enabling a huge volume of trade between European nations and the rest of the world. The 15 largest ships in the world emit as much nitrogen oxide and Sulphur oxide as the world’s 760 million cars. The International Maritime Organization (IMO) estimates that carbon dioxide emissions from shipping were equal to 2.2% of the global emissions in 2012 and expects them to rise 50 to 250 percent by 2050 if no action is taken. European carbon emission monitoring scheme (EU-MRV) & International Maritime Organization – Document Collection System (IMO-DCS) have stringent guideline on daily monitoring of fuel usage and emissions by all sea faring ships. We4Sea has developed SuPREmE a web-based ship performance monitoring platform that provides actionable insights on how to increase fuel efficiency and reduce emissions with no additional hardware installation in the ship. SuPREmE is the easiest, only non-CAPEX monitoring solution of ships, making fuel efficiency and emission reduction easy, fast, affordable and certified for EU-MRV and IMO DCS regulations. SuPREmE is also the only platform that uses big-data based simulation technology to integrate Weather data, Tidal Data and Satellite data in addition to daily captain reports to derive accurate and actionable insights on performance of individual components of ships. During the innovation project, We4Sea will enhance the performance of SuPREmE by improving ability to give insights based on the analysis of data collected, automate data collection from third parties for weather, tidal and satellite data. SuPREmE platform will also be scaled up to handle 10x more ships than the current capacity of 250 ships and will demonstrate financial and non-financial impact by working with 14 ships of Royal Bodewes, A2B-Online and Transpetrol for 6 months

Keywords: digital twin,fuel efficiency,emission control,retrofitting
Validation of diagnostic and/or prognostic miRNAs in triple-negative breast cancer (MIRCAB)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Treating and managing disease
Action type: SME instrument
Countries involved: Belgium
Call: Clinical research for the validation of biomarkers and/or diagnostic medical devices (H2020-SMEINST-1-2014, 2014)
Start date: 2015-01-01
End date: 2015-06-30
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Multiplicom will draft a business plan that is composed of the following parts: (i) selection of miRNAs for which there is substantial scientific evidence that such may be important for the diagnosis, treatment and/or prognosis of triple-negative breast cancer (“TNBC”) patients; (ii) perform a thorough analysis of the intellectual property on the selected miRNAs; (iii) start in-licensing negotiations with licensors regarding relevant intellectual property (iv) select a suitable quantitative multiplex miRNA analysis; (v) plan a European-wide, multi-center, clinical validation of the selected miRNAs using the selected multiplex quantification method (“Validation Study”); and (vi) perform a marketing study regarding the use of miRNA diagnosis/prognosis in TNBC patients; (vii) develop a competitive strategy For part (i) Multiplicom has the support of top-notch clinical scientists (“KOLs”) in the field of miRNA in TNBC. Multiplicom will rely on its internal expertise, and expertise of its consultants to perform (ii) to (vi). This is supported by its track record of developing and commercializing novel highly multiplexed diagnostics (ISO 13485 & CE/IVD). The global 170,000 cases of TNBC (new cases in 2012) constitute the target patient population to be monitored by the validated multiplex miRNA test kit (“Kit”) such that they can be offered the best treatment of what is a multi-billion Euro pharmaceutical opportunity. From presently available data Multiplicom estimates the annual peak sales of the Kit in excess of €5M, with a gross margin of >80%, allowing further expansion of the company including new hires in all departments.

Keywords: mirna,triple negative,breast,cancer,non invasive,biomarker,prognosis,diagnosis
Characterising and Dating Hong Kong's Upland Historic Landscapes (CaDHoKUHL)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Career Restart panel
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: United Kingdom
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2021-09-01
End date: 2024-08-31
Duration (months): 36.0
Total project cost (EUR): 337400.64
EU funding (EUR): 337400.64
Participants: 1
Project status: SIGNED

In tropical East and Southeast Asia, traditional settlement and land-use practices have created highly distinctive historic landscapes, especially in upland areas. This important cultural heritage remains largely unstudied by archaeologists and is consequently both undervalued and at risk. The “CaDHoKUHL” project will address this gap in knowledge by adopting an innovative GIS-based interdisciplinary approach combining landscape archaeology, geosciences, historical research, remote sensing, scientific dating and digital geospatial analysis. Its case-study will be Hong Kong (HK), where the mountainous hinterlands of the densely-populated coastal metropolis have conventionally been regarded as a ‘natural’ landscape, but this is a false picture: historic aerial photos and state-of-the-art remote sensing data reveal upland historic landscapes with features evidencing a diversity of past human activities. Dr Mick Atha (hereafter “the researcher”) will move from HK to the McCord Centre for Landscape at Newcastle University (UNEW) in the UK. There, with supervision by Prof. Sam Turner, he will receive in-depth specialist training in the use of Geographic Information Systems (GIS) as a means to integrate and analyse a diversity of archaeological, historical, and remote sensing datasets and learn how to use Historic Landscape Characterisation (HLC), a method of spatial analysis developed by the host institution. In addition, the researcher will also receive training in geoarchaeological and geochronological methods which, together with the GIS-based use of statistical algorithms, will allow the dating and modelling of upland landscape change through time. The training he receives will not only support original analyses and contribute substantially to archaeological knowledge in HK and the wider region, but will also significantly advance his goal of a reigniting a Europe-based career in interdisciplinary landscape studies and cutting-edge landscape archaeology research.

Keywords: historic landscape characterisation,remote sensing,optically stimulated luminescence,terraces,interdisciplinarity,china,southeast asia,upland landscapes,earth sciences,scientific dating
The ERA Chair for Translational Genomics and Personalized Medicine (TransGeno)

Framework: Horizon 2020 — Spreading excellence and widening participation
Programme: ERA chairs
Theme: Attracting and mobilising the best talents
Action type: Coordination and support actions
Countries involved: Estonia
Call: ERA Chairs (H2020-WIDESPREAD-2014-2, 2014)
Start date: 2015-07-01
End date: 2020-12-31
Duration (months): 66.0
Total project cost (EUR): 2677500.0
EU funding (EUR): 2409700.0
Participants: 1
Project status: CLOSED

TransGeno seeks to hire a top researcher as ERA Chair of Translational Genomics at the University of Tartu (UT). In addition to assembling a highly skilled team to engage in cutting edge translational genomic research, the ERA Chair will promote change throughout the university in several ways: • Establishing the Centre of Translational Genomics as a permanent and sustainable unit within UT • Implementing a PhD curriculum on Translational Genomics - the first one of its kind in Eastern Europe. • Coordinate with other departments to make more efficient and effective use of UT’s research capacity. • Forge partnerships with leading institutions to attract top students and researchers from around the world as well as additional funding. The ERA Chair will also engage with various stakeholders, including: • Health sector business clusters to explore ways to exploit research results • Medical doctors to educate them on how one form of TG information, clinical genomic data, can be useful in everyday practice. • Youth and the general public to popularize genomics and spur young people into STEM sciences. • International researchers by sharing research data and results in as open way as possible, either at ‘green’ or ‘gold’ open access standards. TG applies innovations from genomics to diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. It enables scientists to understand the genetic components of disease, which could lead to a shift from treatment based on symptoms to treatment based on underlying causes of disease. As Europe’s population ages and people must live with chronic diseases for longer this becomes more important. Advances in TG research could lead to early treatment of diseases and in the most ideal scenarios, enable doctors to treat patients before the onset of disease. TransGeno will increase research excellence in Estonia and enable UT to become a world leader in these efforts.

Keywords: translational medicine,genomics,translational genomics,clinical genomics,personalized medicine
Continuous monitoring of hypothermia in elderly people by the novel integrated wearable sensor system based on cellulose hydrogel and metallic nanowires (WEARSENSNANO)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Finland
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2021-06-01
End date: 2023-05-31
Duration (months): 24.0
Total project cost (EUR): 202680.96
EU funding (EUR): 202680.96
Participants: 1
Project status: SIGNED

One common influence of ageing is that it makes the individual susceptible to hypothermia, which is known to be death causing low body temperature (35°C). Hypothermia could be detected at early stages by monitoring various physiological parameters such as ECG signal, skin temperature and body movement. Owing to their flexibility and stretchability, wearable sensors could provide long term continuous recordings of electrophysiological activity for monitoring hypothermia in elder people. Wearable temperature, pressure and strain sensors in forms were studied by many research groups. Those approaches utilized complex and high-cost photolithography techniques, which makes the devices far from commercialization. Besides, the poor processability and lack of skin compatibility of stretchable polymers used as substrates prevents the practical use of these materials. However, solution-processable nanomaterials offer a unique way to reduce the cost and complexity, while cellulose hydrogel is easy processable and skin friendly polymer. Thus, in this project, we aim to develop an integrated wearable temperature and pressure/strain sensor based on solution processable nanowires, and cellulose hydrogel to monitor hypothermia in elder people via measuring pressure, strain and temperature. Pressure/Strain sensor will be prepared via laminating two silver nanowire printed cellulose hydrogels sandwiching a pressure sensitive dielectric layer. Temperature sensor will be fabricated via transfer printing of gold nanowires on the cellulose hydrogel substrate. Next, pressure/strain and temperature sensors will be laminated to form the integrated sensor. Finally, the sensors will be used in real patients. In terms of research quality, infrastructure and services, Prof. Vapaavuori’s lab and Aalto University are quite appropriate for the proposed project. The training is believed to strongly contribute to the researcher’s academic, and scientific career.

Keywords: wearable sensor,hypothermia,pressure sensor,strain sensor,temperature sensor,silver nanowire,gold nanowire,cellulose hydrogel,microcontact printing
Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients (TIMESPAN)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Methods and data
Action type: Research and Innovation actions
Countries involved: Ireland,Iceland,Estonia,Australia,Spain,Germany,Italy,Hong Kong,Norway,Sweden,Sweden,United States,Netherlands,United Kingdom,Denmark,United Kingdom,United Kingdom
Call: Use of Real-World Data to advance research on the management of complex chronic conditions (H2020-SC1-2020-Single-Stage-RTD, 2020)
Start date: 2021-04-01
End date: 2026-03-31
Duration (months): 60.0
Total project cost (EUR): 6811451.0
EU funding (EUR): 5999986.0
Participants: 17
Project status: SIGNED

TIMESPAN's main objective is to advance the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification. Emerging evidence points at substantial comorbidity and shared genetics between adult ADHD and cardiometabolic diseases (i.e., Obesity, Type-2 Diabetes and cardiovascular disease). Inadequate treatment of cardiometabolic disease is strongly associated with premature death and substantial societal costs. National guidelines of cardiometabolic disease have stressed the importance of co-occurring psychiatric disorders. However, even though ADHD is a common (prevalence ≈2 to 5% in adults) and serious complex chronic condition, knowledge about appropriate management of adults with ADHD and co-occurring cardiometabolic disease is lacking. We will address the main objective using existing large-scale cohort studies and linked electronic health record databases in multiple countries with different health care systems. We also use smartphones and wearable devices to obtain novel real-time and multi-parametric measurements of ADHD medication treatment and cardiometabolic risks. The combined use of unparalleled data sources and new technologies for data collection, management, analytics will identify optimized and personalized multidisciplinary treatment approaches that minimise harm and maximise positive changes in disease prognosis and improve treatment discontinuity. TIMESPAN is expected to improve the clinical outcomes, as well as quality of life in adult ADHD patients with co-occurring cardiometabolic disease and also to also facilitates developments of new technological tools for advanced data management, monitoring and analytics for European stakeholders. TIMESPAN strategies to inform clinicians, patients, health authorities, and general public allow for a sustainable implementation of our findings (e.g. recommendations for treatment guidelines).

Keywords: adhd,cardiometabolic disease,national registers,pharmaco epidemiology,pharmaco genomics,mhealth,machine learning,treatment safety,effectiveness and discontinuity,risk stratification